A significant advance in cancer research is emerging with the use of mini-antibodies to re-engage damaged p53. This vital malignant protector protein is frequently inactivated in many kinds of cancer, leading https://hindibookmark.com/story24043318/mini-antibodies-revive-the-p53-protein-a-promising-hope-for-tumor-management